Smith Group Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.6M | Buy |
|
|||||
|
2025
Q1 | $22.1M | Buy |
|
|||||
|
2024
Q4 | $17.6M | Sell |
|
|||||
|
2024
Q3 | $20.3M | Buy |
|
|||||
|
2024
Q2 | $20.1M | Buy |
|
|||||
|
2024
Q1 | $17.2M | Buy |
|
|||||
|
2023
Q4 | $14.9M | Buy |
|
|||||
|
2022
Q1 | $4.97M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $6.91M | Sell |
|
|||||
|
2020
Q3 | $12.1M | Sell |
|
|||||
|
2020
Q2 | $12.9M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $9.74M | Sell |
|
|||||
|
2017
Q3 | $19.9M | Sell |
|
|||||
|
2017
Q2 | $24.6M | Buy |
|